Detection of Cardiac Amyloidosis with Us2.ai –Now FDA cleared and CE marked
AI Echocardiography Tool Now Approved to Help Doctors Detect Cardiac Amyloidosis — A Commonly Missed Heart Disease Singapore – July 7, 2025 – Us2.ai, a global leader in artificial intelligence (AI) for automated analysis of heart ultrasound scans (echocardiography), has... Read More →
PanTher Therapeutics Initiates Phase 1b clinical trial of absorbable, long-lasting, high-dose chemotherapy patch for pancreatic cancer
AUSTIN, Texas–(BUSINESS WIRE)–PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage company redefining cancer treatment with therapeutics administered continuously and exclusively at the tumor site, today announced that the first patient has been treated with PTM-101 in a Phase 1b clinical... Read More →
Samsung acquiring Seattle tech startup Xealth to boost digital health ambitions
Samsung Electronics is acquiring Seattle-based digital health startup Xealth, aiming to expand its footprint in healthcare. Founded in 2017 as a spinout of the Providence health system, Xealth helps healthcare providers prescribe and manage digital health tools. Its system is... Read More →
Cedars-Sinai backs AI startup featuring Dasi Simulations
Cedars-Sinai Ventures is investing in an AI startup focused on structural heart care, Columbus (Ohio) Business First reported. The venture capital arm of the Los Angeles-based health system participated in a $5 million funding round in June for Dasi Simulations,... Read More →
Moon Surgical Receives FDA Clearance for Maestro™ Connectivity and Predetermined Change Control Plan for AI-Powered ScoPilot®
PARIS and SAN FRANCISCO, July 2, 2025 /PRNewswire/ — Moon Surgical, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for two major advancements to its Maestro System: connectivity of the platform to power the Maestro Insights... Read More →
DLA Piper advises ImmersiveTouch in its strategic investment by HealthpointCapital
DLA Piper advised ImmersiveTouch, a leading digital surgery company, in its strategic investment by HealthpointCapital, a private equity firm focused exclusively on musculoskeletal healthcare to acquire a majority of the equity interests of the company. ImmersiveTouch offers an FDA 510(k)-cleared... Read More →
CroíValve Announces Funding from Horizon Europe EIC Accelerator
DUBLIN–(BUSINESS WIRE)–CroíValve, a pioneering medical device company innovating a better way to help more patients suffering from Tricuspid Regurgitation (TR), was awarded funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Programme. Part of the EU’s Horizon Europe 2021-2027 Research... Read More →
InterShunt initiates study of device for heart failure treatment
The first procedure in the US using the device was performed at The Christ Hospital Health Network in Ohio. InterShunt Technologies has initiated the EASE HF2 early feasibility study to assess the InterShunt percutaneous atrial shunt catheter (PAS-C) system, intended... Read More →
Demonstration of Biomechanical Safety When Applying a Flowable Hydrogel Tendon Protector: A Cadaver Study featuring TYBR Health
B3 GEL™ SYSTEM SUPPORTING RESEARCH: What Happens When You “Overapply” Tendon Protection? Surgeons may question their application of tendon protection devices: ” ?” A cadaveric study, carried out in conjunction with researchers at the University of Virginia, has the answer.... Read More →
Breakthrough in Cancer Care: Multi4 Medical’s New Technology Cleared by FDA
Swedish MedTech company Multi4 Medical, chaired by renowned investor Erik Selin, has received FDA clearance for its patended technology for automated cancer treatment. The decision means that Multi4 is now approved for commercial sale in the U.S., the world’s largest... Read More →